Ynvisible Interactive Inc. develops ultra-low-power printed e-paper display technology for product applications that use flexible electronics and roll-to-roll manufacturing. News about YNVYF commonly covers commercialization of printed e-paper displays, customer and regional partnerships, medical and healthcare applications, automotive development work, smart-label programs, industrial monitoring, logistics, IoT and digital signage use cases.
Company updates also include manufacturing capacity, technology-transfer relationships, trade-show demonstrations, board changes and financing activity such as private placements. The recurring news themes center on Ynvisible's transition from technology development toward commercial orders and scalable production for printed electronics markets.
Ynvisible Interactive (YNVYF) announced that Michael Kott resigned from its Board of Directors, with the resignation effective October 10, 2026.
Kott will continue to support the company in an advisory capacity. Ynvisible plans to evaluate opportunities to strengthen its Board as it pursues its commercial and corporate objectives.
Ynvisible Interactive (YNVYF) has agreed through its subsidiary to sell its Swedish roll-to-roll production assets to Cellfion for CAD$960,000. Payment is in cash, with closing scheduled for October 2026. The transfer includes related equipment, site service contracts, the premises lease and production staff. Ynvisible retains all intellectual property and inventory.
At closing, the companies will enter into profit-sharing and potential future service agreements. Ynvisible expects annual operating expenses to fall by more than CAD$800,000. Its manufacturing model uses Portugal for custom, lower-volume work and CCL for high-volume production. Closing depends on Cellfion signing a binding landlord agreement; either party may terminate if that condition is not met or waived by closing.
Ynvisible Interactive (YNVYF) announced progress in its commercial program with Sapphiros, a CFO transition, and a move to semi-annual financial reporting, dated September 11, 2026.
Sapphiros is advancing clinical trials for its digital diagnostic platform, targeting completion in Q4 2026 and a planned 2027 commercial launch, with Ynvisible’s ultra-low-power e-paper displays integrated and preparations underway for high-volume manufacturing. The companies project potential commercialization volumes in the high millions of units annually.
Ynvisible appointed Inês Paramés as Chief Financial Officer effective September 1, 2026, succeeding Darren Urquhart. The company also elected to adopt CSA’s semi-annual reporting regime, starting with the quarter ending September 30, 2026, to reduce compliance costs and focus resources on commercial execution.
Ynvisible (OTCQB: YNVYF) reported an operational update for January–May 2026, with delivery of over 30,000 e-paper display units across industrial and healthcare customers and about CAD 200,000 in contract manufacturing service revenue.
Shipments support clinical trials, recurring industrial orders, and sustainability-focused hygiene applications.
Ynvisible (OTCQB: YNVYF) secured over CAD$400,000 (about SEK 3.0 million) in grants to advance sustainable manufacturing and medical-grade e-paper displays.
Funding backs the R2R-MICROBAT battery project and MedPrint, which targets scalable production capacity up to 10 million medical e-paper units annually in Norrköping.
Ynvisible (OTC:YNVYF) closed a first tranche of a non‑brokered private placement on March 26, 2026, issuing 5,770,000 Units at $0.10 each for gross proceeds of $577,000. Each Unit includes one share and one warrant exercisable at $0.14 for three years.
The TSX Venture Exchange granted a 30‑day extension to April 24, 2026 to complete up to 20,000,000 Units. Securities are subject to a statutory hold until July 26, 2026. Funds are for working capital and general corporate purposes.
Ynvisible (OTCQB: YNVYF) received a Letter of Intent from Sapphiros for a three-year exclusive supply arrangement to provide printed e-paper displays for certain lateral flow and molecular diagnostic tests.
Clinical studies and an FDA regulatory pathway are underway; initial commercial sales are reported as underway and expected to accelerate through 2026, marking Ynvisible's first commercial entry into medical diagnostics after joint development since 2024.
Ynvisible (OTCQB: YNVYF) appointed Michael Kott to its Board of Directors effective March 9, 2026. Kott is founder and CEO of CM-Equity AG, with experience in capital markets, governance, IPOs, and cross-border investments. The company highlighted his expertise in scaling tech firms and printed e-paper display strategy.
The appointment is positioned to support Ynvisible's strategic development, investor outreach, and expansion in ultra-low-power printed e-paper displays and printed electronics markets.
Ynvisible (OTCQB: YNVYF) announced a collaboration with a globally recognized automotive manufacturer to co-develop a new e-paper product for automotive applications, with development work currently underway and details withheld for patent protection. The company emphasized the opportunity in the automotive sector, citing industry size and vehicle sales forecasts and framing the project as a step toward high-volume commercialization and improved sustainability, energy consumption, and cost efficiency. The company also announced the resignation of director Felix Karlsson, effective January 23, 2026.
Ynvisible Interactive (OTCQB: YNVYF) reported that 2025 marked a transition from development to commercial execution, citing follow-on orders, scalable manufacturing, and geographic expansion. Highlights include a follow-on order of >10,000 units for an at-home diagnostic platform with customer-projected volumes to 10 million units annually, delivery and follow-on orders in industrial applications (10,000+ delivered; 30,000 follow-on supporting ~€500,000 annual recurring revenue), a production partnership with CCL Design, a new roll-to-roll facility in Norrköping, Sweden, and a regional partner in Brazil. At CES 2026 the company reported 120+ qualified sales leads and 300+ direct customer interactions. 2026 priorities are converting engagements into commercial supply agreements, scaling manufacturing, and expanding the U.S. commercial footprint.